Transvascular lead extraction (TLE) is associated with technical limitations and complications, including fragmentation of the lead body and its uncontrolled translocation.
This article reports the case of a 50-year-old female with an atrial valve replaced 32 years ago, paroxysmal atrial fibrillation, congestive heart failure with a 40% ejection fraction, and Epic VR (St. Jude Medical, USA) implantable cardioverterdefibrillator (ICD) with a Linox S 65 single-coil active defibrillation lead (Biotronik, Germany) implanted in 2009. She was referred for TLE because of damage to the defibrillation lead.
During TLE, the defibrillation lead insulation was pulled out below the inserted Liberator locking stylet (Cook Medical, USA), stretching the coil-wire and leaving the distal part of the lead (Fig. 1A) . Attempts to remove the remains of the lead through femoral access using a Needle's Eye Snare (Cook Medical, USA) were unsuccessfulthe coil-wire was torn and a loose fragment translocated to the hepatic vein (Fig. 1B) . The broken lead fragment was successfully removed using a bioptome (Jawz™ Endomyocardial Biopsy Forceps, Argon Medical Devices, USA) which was inserted through the transseptal Agilis™ NxT steerable introducer (SJM, USA) placed in the hepatic vein (Fig. 1C, Suppl. Video 1) .
Fragmented parts of extracted leads may be a source of venous embolism. The real clinical significance of a small metallic wire left in the hepatic vein is still unknown with respect to potential infectious and mechanical consequences, but it was shown that the decision to remove the wire from the hepatic vein was effective and safe (Fig. 1D) . 
